Adaptive Biotechnologies
Price & Volume
Stats
See more52W Range | $12-$26.87 |
Market Cap | $4.1B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $308M |
Revenue Growth (YoY) | 21.5% |
Gross Profit (12 Mos) | $144.6M |
Diluted EPS | -$0.40 |
News
See moreYahoo Finance • 2 months ago
Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku
Yahoo Finance • 2 months ago
An Adaptive Biotechnologies Insider Sold $8.5 Million in Stock After an 85% Run
Yahoo Finance • 2 months ago
Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
Yahoo Finance • 2 months ago
BTIG Maintains a Buy Rating on Adaptive Biotechnologies (ADPT)
About
CEO | Mr. Chad M. Robins M.B.A. |
CFO | Mr. Kyle Piskel |
Address | 1165 Eastlake Avenue East, Seattle, WA, United States, 98109 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 624 |